Clinical Trial Update: 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial of 131-I-TM-601 in adults with recurrent high-grade glioma, sponsored by TransMolecular; the curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma Multiforme
• Gliosarcoma
• Oligoastrocytoma

Drugs mentioned

• 131-I-TM-601 (Iodine-131 labeled TM-601)

Snippet

Sponsor: TransMolecular | Conditions: Malignant Glioma, Glioblastoma Multiforme | Phase 2 | Status: UNKNOWN